SignatureFD
NRIX icon

SignatureFD’s Nurix Therapeutics NRIX Stock Holding History

SignatureFD’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.5K Hold
655
– – ﹤0.01% 2534
2026
Q2 		$15.9K Buy
655
+102
+18% +$1.74K ﹤0.01% 2447
2026
Q1 		$8.57K Hold
553
– – ﹤0.01% 2572
2025
Q4 		$10.5K Buy
553
+94
+20% +$1.35K ﹤0.01% 2408
2025
Q3 		$4.24K Sell
459
-66
-13% -$685 ﹤0.01% 2736
2025
Q2 		$5.98K Sell
525
-45
-8% -$486 ﹤0.01% 2541
2025
Q1 		$6.77K Hold
570
– – ﹤0.01% 2499
2024
Q4 		$10.7K Hold
570
– – ﹤0.01% 2336
2024
Q3 		$12.8K Hold
570
– – ﹤0.01% 2243
2024
Q2 		$11.9K Buy
570
+87
+18% +$1.36K ﹤0.01% 2197
2024
Q1 		$7.1K Sell
483
-197
-29% -$2.12K ﹤0.01% 2430
2023
Q4 		$7.02K Sell
680
-226
-25% -$1.55K ﹤0.01% 2402
2023
Q3 		$7.12K Sell
906
-108
-11% -$986 ﹤0.01% 2366
2023
Q2 		$10.1K Sell
1,014
-10
-1% -$102 ﹤0.01% 2229
2023
Q1 		$9.09K Buy
1,024
+1,014
+10,140% +$10.6K ﹤0.01% 2256
2022
Q4 		$110 Buy
+10
New +$121 ﹤0.01% 3228
2022
Q2 		– Sell
-48
Closed -$1K – 3273
2022
Q1 		$1K Buy
48
+42
+700% +$746 ﹤0.01% 3028
2021
Q4 		$0 Sell
6
-13
-68% -$394 ﹤0.01% 3214
2021
Q3 		$1K Sell
19
-7
-27% -$216 ﹤0.01% 2872
2021
Q2 		$1K Buy
+26
New +$763 ﹤0.01% 2784

Other funds holding NRIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.6B AUM 38.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

SignatureFD's NRIX Position: Q3 2026 in Review

SignatureFD held its Nurix Therapeutics (NRIX) position steady in Q3 2026 at 655 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

SignatureFD first reported a position in NRIX in Q2 2021 and has held it in 20 quarters since. The position peaked at $15.9K in Q2 2026. 91 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

  • SignatureFD held 655 shares of Nurix Therapeutics worth $15.5K as of Q3 2026.
  • SignatureFD left its Nurix Therapeutics share count unchanged in Q3 2026.
  • Nurix Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2534 holding.
  • SignatureFD first reported a position in Nurix Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • SignatureFD's Nurix Therapeutics position peaked at $15.9K in Q2 2026.
  • 91 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.